COVID-19 as a Risk Factor for Alzheimer’s Disease

Cites (254)

Items 201–254 of 254

1. Microglial Implications in SARS-CoV-2 Infection and COVID-19: Lessons From Viral RNA Neurotropism and Possible Relevance to Parkinson’s Disease
   Ifeoluwa Oluleke Awogbindin, Benneth Ben‐Azu, Babatunde Adebiyi Olusola, Elizabeth Toyin Akinluyi, Philip Adeyemi Adeniyi, Thérèse Di Paolo, Marie‐Ève Tremblay · 2021 · Frontiers in Cellular Neuroscience
2. Assessing the importance of interleukin-6 in COVID-19
   Luke Y. C. Chen, Ryan L. Hoiland, Sophie K. Stukas · 2021 · The Lancet Respiratory Medicine
3. SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients
   Luigi Chiricosta, Agnese Gugliandolo, Emanuela Mazzon · 2021 · International Journal of Molecular Sciences
4. Galectins and Neuroinflammation
   Hung-Lin Chen, Fang Liao, Teng‐Nan Lin, Fu‐Tong Liu · 2014 · Advances in neurobiology
5. Longitudinal Performance of Plasma Neurofilament Light and Tau in Professional Fighters: The Professional Fighters Brain Health Study
   Charles B. Bernick, Henrik Zetterberg, Guogen Shan, Sarah Jane Banks, Kaj Blennow · 2018 · Journal of Neurotrauma
6. SARS-CoV-2 involvement in central nervous system tissue damage
   Mirna Sabra, Firas H. Kobeissy, Maya Bizri, Muhammad Ali Haidar, Zaynab Shakkour, Mohammad Amine Reslan, Nadine Al-Haj, Perla Chamoun, Karl John Habashy, Hasan Kaafarani et al. · 2021 · Neural Regeneration Research
7. The Musculoskeletal Involvement After Mild to Moderate COVID-19 Infection
   Patty Karina dos Santos, Emilly Sigoli, Lorenna J.G. Bragança, Anabelle Silva Cornachione · 2022 · Frontiers in Physiology
8. Use of diuretics is associated with reduced risk of Alzheimer's disease: the Cache County Study
   Yi‐Fang Chuang, John C.S. Breitner, Yen‐Ling Chiu, Ara S. Khachaturian, Kathleen M. Hayden, Chris Corcoran, JoAnn T. Tschanz, Maria C. Norton, Ron Munger, Kathleen Anne Welsh-Bohmer et al. · 2014 · Neurobiology of Aging
9. Genetic polymorphisms of interleukin genes and the risk of Alzheimer's disease: An update meta-analysis
   Myung-Jin Mun, Jin-Ho Kim, Ji-Young Choi, Won‐Cheoul Jang · 2016 · Meta Gene
10. Why Severe COVID-19 Patients Are at Greater Risk of Developing Depression: A Molecular Perspective
    Ana Paula Bouças, Jakeline Rheinheimer, Jim Lagopoulos · 2020 · The Neuroscientist
11. Demyelination as a result of an immune response in patients with COVID-19
    Zahra Shabani · 2021 · Acta Neurologica Belgica
12. IL-6 polymorphisms: a useful genetic tool for inflammation research?
    Patricia M. Woo, Steve Eric Humphries · 2013 · Journal of Clinical Investigation
13. Microglia and immunotherapy in Alzheimer’s disease
    Qingqing Li, Yingying Wu, Jichun Chen, Aiguo Xuan, Xiao Wang · 2021 · Acta Neurologica Scandinavica
14. Spectrum, risk factors and outcomes of neurological and psychiatric complications of COVID-19: a UK-wide cross-sectional surveillance study
    Amy Ross Russell, Marc Hardwick, Athavan Jeyanantham, Laura M White, Saumitro Deb, Girvan Burnside, Harriet M. Joy, Craig J. Smith, Thomas Arthur Pollak, Timothy R. Nicholson et al. · 2021 · Brain Communications
15. The rising burden of Alzheimer's disease mortality in rural America
    Jessica Y. Ho, Yujin Franco · 2022 · SSM - Population Health
16. TREM-2 is a sensor and activator of T cell response in SARS-CoV-2 infection
    Yongjian Wu, Manni Wang, Huan Yin, Siqi Ming, Xingyu Li, Guanmin Jiang, Ye Liu, Pei‐Hui Wang, Guangde Zhou, Lei Liu et al. · 2021 · Science Advances
17. Type I Interferons in COVID-19 Pathogenesis
    Enrico Palermo, Daniele Di Carlo, Marco Sgarbanti, John B. Hiscott · 2021 · Biology
18. Recovery from SARS-CoV-2 infection is associated with serum BDNF restoration
    David Azoulay, Mona Shehadeh, Svetlana Rodin Chepa · 2020 · Journal of Infection
19. COVID-19 “Rebound” associated with nirmatrelvir/ritonavir pre-hospital therapy
    James Coulson, A. Adams, L.A. Gray, Andrew Evans · 2022 · Journal of Infection
20. Non-hospitalized Adults with COVID-19 Differ Noticeably from Hospitalized Adults in Their Demographic, Clinical, and Social Characteristics
    Sharon Horesh Bergquist, Clyde Partin, David L. Roberts, James B. O’Keefe, Elizabeth J. Tong, Jennifer Zreloff, Thomas L. Jarrett, Miranda A. Moore · 2020 · SN Comprehensive Clinical Medicine
21. Investigation of Genetic Variations of IL6 and IL6R as Potential Prognostic and Pharmacogenetics Biomarkers: Implications for COVID-19 and Neuroinflammatory Disorders
    Claudia Strafella, Valerio Caputo, Andrea Termine, Shila Barati, Carlo Caltagirone, Emiliano Giardina, Raffaella Cascella · 2020 · Life
22. Small molecule therapeutics for COVID-19: repurposing of inhaled furosemide
    Zhiyu Wang, Yanfei Wang, Prachi Vilekar, Seung‐Pil Yang, Mayuri Gupta, Myong In Oh, Autumn R. Meek, Lisa M. Doyle, Laura Villar, Anja Brennecke et al. · 2020 · PeerJ
23. COVID-19, Neuropathology, and Aging: SARS-CoV-2 Neurological Infection, Mechanism, and Associated Complications
    Rajkumar Singh Kalra, Jaspreet Kaur Dhanjal, Avtar S. Meena, Vishal C. Kalel, Surya Dahiya, Birbal Singh, Saikat Dewanjee, Ramesh J. L. Kandimalla · 2021 · Frontiers in Aging Neuroscience
24. COVID-19 Outcome Relates With Circulating BDNF, According to Patient Adiposity and Age
    Luciéle Guerra Minuzzi, Marília Cerqueira Leite Seelaender, Bruna Spolador de Alencar Silva, Eduardo del Bosco Brunetti Cunha, Marina de Castro Deus, Franciane F. Vasconcellos, Luis Felipe Marqueze, Ana Carolina Gadotti, Cristina Pellegrino Baena, Telmo Santos Pereira et al. · 2021 · Frontiers in Nutrition
25. Neurological sequelae of COVID-19: a review
    Christopher Peterson, Ashish Sarangi, Fariha Bangash · 2021 · The Egyptian Journal of Neurology Psychiatry and Neurosurgery
26. Covid-19: What is the evidence for the antiviral molnupiravir?
    Andy Extance · 2022 · BMJ
27. Angiotensin II type 1 receptor blockade by telmisartan prevents stress-induced impairment of memory via HPA axis deactivation and up-regulation of brain-derived neurotrophic factor gene expression
    Dominik Wincewicz, Agnieszka Juchniewicz, Napoleon Waszkiewicz, Jan Józef Braszko · 2016 · Pharmacology Biochemistry and Behavior
28. Furosemide as a Probe Molecule for the Treatment of Neuroinflammation in Alzheimer's Disease.
    Zhi-Yu Wang, Prachi Vilekar, Jun-Bo Huang, D. Weaver · 2020 · ACS Chemical Neuroscience
29. Long-COVID: Cognitive deficits (brain fog) and brain lesions in non–hospitalized patients
    Jacques Hugon · 2021 · La Presse Médicale
30. Renin–angiotensin system gene expression and neurodegenerative diseases
    Benjamin I. Goldstein, Robert Charles Speth, Malav Suchin Trivedi · 2016 · Journal of the Renin-Angiotensin-Aldosterone System
31. IL-6 deficiency alters spatial memory in 4- and 24-month-old mice
    Izabela Bialuk, Andrzej Taranta, Maria M. Winnicka · 2018 · Neurobiology of Learning and Memory
32. Genetic variability of inflammation and oxidative stress genes does not play a major role in the occurrence of adverse events of dopaminergic treatment in Parkinson’s disease
    Sara Redenšek, Dušan Flisar, Maja Kojović, Milica Gregorič Kramberger, Dejan Georgiev, Zvezdan Pirtošek, Maja Trošt, Vita Dolžan · 2019 · Journal of Neuroinflammation
33. Increased ileal bile acid binding protein and galectin-9 are associated with mild cognitive impairment and Alzheimer's disease
    Xin Wang, Ye Niu, Chen-xi Yue, Shuang Fu, Ruitao Wang · 2019 · Journal of Psychiatric Research
34. Multisystem Inflammatory Syndrome Associated With COVID-19 With Neurologic Manifestations in a Child: A Brief Report
    Milena de Paulis, Danielle Bruna Leal Oliveira, Rodolfo P. Vieira et al. · 2020 · The Pediatric Infectious Disease Journal
35. “Brain Fog” by COVID-19 or Alzheimer’s Disease? A Case Report
    Jordi A. Matías‐Guiu, Cristina Delgado‐Alonso, Miguel Yus, Carmen Polidura, Natividad Gómez‐Ruiz, María Valles‐Salgado, Isabel Ortega‐Madueño, María Nieves Cabrera‐Martín, Jorge Matías‐Guiu · 2021 · Frontiers in Psychology
36. Clinical Features and Outcomes of Patients with Dementia Compared to an Aging Cohort Hospitalized During the Initial New York City COVID-19 Wave
    Amro A. Harb, Ruijun Chen, Herbert S Chase, Karthik Natarajan, James McC. Noble · 2021 · Journal of Alzheimer s Disease
37. Dementia as Risk Factor for Severe Coronavirus Disease 2019: A Case-Control Study
    Mariantonietta Pisaturo, Federica Calò, Antonio Russo, Clarissa Camaioni, Agnese Giaccone, Biagio Pinchera, Ivan Gentile, Filomena Simeone, Angelo Iodice, Paolo Maggi et al. · 2021 · Frontiers in Aging Neuroscience
38. Neuro-COVID-19: an insidious virus in action
    Jolanta Bratosiewicz‐Wąsik · 2021 · Neurologia i Neurochirurgia Polska
39. Association of Alzheimer’s Disease with COVID-19 Susceptibility and Severe Complications: A Nationwide Cohort Study
    Seok Jong Chung, Yoonkyung Chang, Jimin Jeon, Jae Il Shin, Tae‐Jin Song, Jinkwon Kim · 2022 · Journal of Alzheimer s Disease
40. The Predictive Value of Plasma Galectin-3 for Ards Severity and Clinical Outcome
    Zhiheng Xu, Xi Li, Yongbo Huang, Pu Mao, Sulong Wu, Baoxin Yang, Yuanyuan Yang, Kangxie Chen, Xiaoqing Liu, Yimin Li · 2016 · Shock
41. Hippocampus and basal ganglia as potential sentinel sites for ischemic pathology after resuscitated cardiac arrest
    Mattias Haglund, Eva Lindberg, Elisabet M. Englund · 2019 · Resuscitation
42. Is Inhaled Furosemide a Potential Therapeutic for COVID-19?
    Anja Brennecke, Laura Villar, Zhiyu Wang · 2020 · The American Journal of the Medical Sciences
43. Regulated Intramembrane Proteolysis of ACE2: A Potential Mechanism Contributing to COVID-19 Pathogenesis?
    Sandra Milena González, Abu Bakar Siddik, Ruey‐Chyi Su · 2021 · Frontiers in Immunology
44. Design, synthesis, and biological evaluation of furosemide analogs as therapeutics for the proteopathy and immunopathy of Alzheimer's disease
    Zhiyu Wang, Yanfei Wang, Jagadeesh Prasad Pasangulapati, Kurt R. Stover, Xiaojing Liu, Stephanie Schier, Donald Fredric Weaver · 2021 · European Journal of Medicinal Chemistry
45. Intercepting Dementia: Awareness and Innovation as Key Tools
    Emanuele Brai, Alessandro Tonacci, Victòria Brugada-Ramentol, Federica D’Andrea, Lavinia Auber Alberi · 2021 · Frontiers in Aging Neuroscience
46. The NLRP3 Inflammasome in the Pathogenesis and Treatment of Alzheimer’s Disease
    Mahdieh Golzari-Sorkheh, Carla E. Brown, Donald Fredric Weaver, Mark A. Reed · 2021 · Journal of Alzheimer s Disease
47. Possible immunity, inflammation, and oxidative stress mechanisms of Alzheimer’s disease in COVID-19 patients
    Haili Wang, Rongyin Qin, Jun Zhang, Yingzhu Chen · 2020 · Clinical Neurology and Neurosurgery
48. Care for Older People with Dementia During COVID-19 Pandemic
    Demelza Emmerton, Ahmed H. Abdelhafiz · 2021 · SN Comprehensive Clinical Medicine
49. Evaluation of the relationship between TREM‐1/TREM‐2 ratio and clinical course in COVID‐19 pneumonia
    Ferhan Kerget, Buğra Kerget, Sibel İba Yılmaz, Ahmet Kızıltunç · 2021 · International Journal of Clinical Practice
50. Association between Dementia and Clinical Outcome after COVID-19: A Nationwide Cohort Study with Propensity Score Matched Control in South Korea
    Sheng‐Min Wang, See Hyun Park, Nak-Young Kim, Dong Woo Kang, Hae-Ran Na, Yoo Hyun Um, Seunghoon Han, Sung‐Soo Park, Hyun Kook Lim · 2021 · Psychiatry Investigation
51. Post-acute Sequelae of SARS-CoV-2 Infection and Subjective Memory Problems
    Esther S. Oh, Tracy D. Vannorsdall, Ann Marie Parker · 2021 · JAMA Network Open
52. Early short-course corticosteroids and furosemide combination to treat non-critically ill COVID-19 patients: An observational cohort study
    Jean-Philippe Kévorkian, Jean‐Pierre Riveline, Claire Vandiedonck · 2020 · Journal of Infection
53. Plasma biomarkers of neurodegeneration and neuroinflammation in hospitalized COVID‐19 patients with and without new neurological symptoms
    Allal Boutajangout, Jennifer Ann Frontera, Ludovic Debure · 2021 · Alzheimer s & Dementia
54. Editor's Perspective: “Connecting the Dots” from Blood Brain Barrier Dysfunction to Neuroinflammation and Alzheimer’s Disease
    Kenneth Maiese · 2014 · Current Neurovascular Research